Cargando…
Meta-analysis of Individual Patient Data After Kissing Stent Treatment for Aortoiliac Occlusive Disease
Purpose: To evaluate short- and long-term technical and clinical outcomes after kissing stent treatment of aortoiliac occlusive disease (AIOD) based on an individual participant data (IPD) meta-analysis. Materials and Methods: A search of the Scopus database identified 156 articles on KS treatment o...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330696/ https://www.ncbi.nlm.nih.gov/pubmed/30499352 http://dx.doi.org/10.1177/1526602818810535 |
_version_ | 1783387015543259136 |
---|---|
author | Groot Jebbink, Erik Holewijn, Suzanne Versluis, Michel Grimme, Frederike Hinnen, Jan Willem Sixt, Sebastian Angle, John F. Dorigo, Walter Reijnen, Michel M. P. J. |
author_facet | Groot Jebbink, Erik Holewijn, Suzanne Versluis, Michel Grimme, Frederike Hinnen, Jan Willem Sixt, Sebastian Angle, John F. Dorigo, Walter Reijnen, Michel M. P. J. |
author_sort | Groot Jebbink, Erik |
collection | PubMed |
description | Purpose: To evaluate short- and long-term technical and clinical outcomes after kissing stent treatment of aortoiliac occlusive disease (AIOD) based on an individual participant data (IPD) meta-analysis. Materials and Methods: A search of the Scopus database identified 156 articles on KS treatment of AIOD; of these 22 met the inclusion criteria. Authors of 19 articles with contact information were approached to join an IPD consortium. Eight author groups responded and 5 provided anonymized data for merging into an IPD database. The number of included procedures was equal before and after 2005. The primary study outcome was the cumulative patency at 24 months. Secondary outcomes were patency at up to 60 months, complications, and changes in Rutherford category and ankle-brachial index. The predictive value of stent protrusion length, pre-/postdilation, stent type, and patient demographics on primary patency were examined with Cox proportional hazard modeling; outcomes are reported as the hazard ratio (HR). The Kaplan-Meier method was employed to estimate patency rates. Results: In total, 605 (40.9%) of 1480 patients presented in the literature were included in the IPD analysis. The indication for intervention was intermittent claudication in 84.2% and critical limb ischemia in 15.8%. Lesions were classified as TransAtlantic Inter-Society Consensus (TASC) A or B in 52.8% and TASC C and D in 47.2%. The overall primary patency estimate was 81% at 24 months. Primary patency significantly increased after 2005 (p=0.005). Cox regression analysis revealed only age as a significant predictor of sustained primary patency (HR 0.60, p<0.005). Any previous endovascular intervention (HR 2.52, p=0.02) was the main predictor for loss of secondary patency; history of cardiovascular disease (HR 0.27, p=0.04) was the main predictor of sustained secondary patency. Conclusion: The kissing stent technique has a good safety profile and acceptable patency rates up to 2 years, even in TASC C and D lesions, supporting an endovascular-first approach for AIOD. |
format | Online Article Text |
id | pubmed-6330696 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-63306962019-01-29 Meta-analysis of Individual Patient Data After Kissing Stent Treatment for Aortoiliac Occlusive Disease Groot Jebbink, Erik Holewijn, Suzanne Versluis, Michel Grimme, Frederike Hinnen, Jan Willem Sixt, Sebastian Angle, John F. Dorigo, Walter Reijnen, Michel M. P. J. J Endovasc Ther Lower Limb Interventions Purpose: To evaluate short- and long-term technical and clinical outcomes after kissing stent treatment of aortoiliac occlusive disease (AIOD) based on an individual participant data (IPD) meta-analysis. Materials and Methods: A search of the Scopus database identified 156 articles on KS treatment of AIOD; of these 22 met the inclusion criteria. Authors of 19 articles with contact information were approached to join an IPD consortium. Eight author groups responded and 5 provided anonymized data for merging into an IPD database. The number of included procedures was equal before and after 2005. The primary study outcome was the cumulative patency at 24 months. Secondary outcomes were patency at up to 60 months, complications, and changes in Rutherford category and ankle-brachial index. The predictive value of stent protrusion length, pre-/postdilation, stent type, and patient demographics on primary patency were examined with Cox proportional hazard modeling; outcomes are reported as the hazard ratio (HR). The Kaplan-Meier method was employed to estimate patency rates. Results: In total, 605 (40.9%) of 1480 patients presented in the literature were included in the IPD analysis. The indication for intervention was intermittent claudication in 84.2% and critical limb ischemia in 15.8%. Lesions were classified as TransAtlantic Inter-Society Consensus (TASC) A or B in 52.8% and TASC C and D in 47.2%. The overall primary patency estimate was 81% at 24 months. Primary patency significantly increased after 2005 (p=0.005). Cox regression analysis revealed only age as a significant predictor of sustained primary patency (HR 0.60, p<0.005). Any previous endovascular intervention (HR 2.52, p=0.02) was the main predictor for loss of secondary patency; history of cardiovascular disease (HR 0.27, p=0.04) was the main predictor of sustained secondary patency. Conclusion: The kissing stent technique has a good safety profile and acceptable patency rates up to 2 years, even in TASC C and D lesions, supporting an endovascular-first approach for AIOD. SAGE Publications 2018-11-30 2019-02 /pmc/articles/PMC6330696/ /pubmed/30499352 http://dx.doi.org/10.1177/1526602818810535 Text en © The Author(s) 2018 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Lower Limb Interventions Groot Jebbink, Erik Holewijn, Suzanne Versluis, Michel Grimme, Frederike Hinnen, Jan Willem Sixt, Sebastian Angle, John F. Dorigo, Walter Reijnen, Michel M. P. J. Meta-analysis of Individual Patient Data After Kissing Stent Treatment for Aortoiliac Occlusive Disease |
title | Meta-analysis of Individual Patient Data After Kissing Stent Treatment for Aortoiliac Occlusive Disease |
title_full | Meta-analysis of Individual Patient Data After Kissing Stent Treatment for Aortoiliac Occlusive Disease |
title_fullStr | Meta-analysis of Individual Patient Data After Kissing Stent Treatment for Aortoiliac Occlusive Disease |
title_full_unstemmed | Meta-analysis of Individual Patient Data After Kissing Stent Treatment for Aortoiliac Occlusive Disease |
title_short | Meta-analysis of Individual Patient Data After Kissing Stent Treatment for Aortoiliac Occlusive Disease |
title_sort | meta-analysis of individual patient data after kissing stent treatment for aortoiliac occlusive disease |
topic | Lower Limb Interventions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330696/ https://www.ncbi.nlm.nih.gov/pubmed/30499352 http://dx.doi.org/10.1177/1526602818810535 |
work_keys_str_mv | AT grootjebbinkerik metaanalysisofindividualpatientdataafterkissingstenttreatmentforaortoiliacocclusivedisease AT holewijnsuzanne metaanalysisofindividualpatientdataafterkissingstenttreatmentforaortoiliacocclusivedisease AT versluismichel metaanalysisofindividualpatientdataafterkissingstenttreatmentforaortoiliacocclusivedisease AT grimmefrederike metaanalysisofindividualpatientdataafterkissingstenttreatmentforaortoiliacocclusivedisease AT hinnenjanwillem metaanalysisofindividualpatientdataafterkissingstenttreatmentforaortoiliacocclusivedisease AT sixtsebastian metaanalysisofindividualpatientdataafterkissingstenttreatmentforaortoiliacocclusivedisease AT anglejohnf metaanalysisofindividualpatientdataafterkissingstenttreatmentforaortoiliacocclusivedisease AT dorigowalter metaanalysisofindividualpatientdataafterkissingstenttreatmentforaortoiliacocclusivedisease AT reijnenmichelmpj metaanalysisofindividualpatientdataafterkissingstenttreatmentforaortoiliacocclusivedisease |